PETER JONES to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications PETER JONES has written about Randomized Controlled Trials as Topic.
Connection Strength
0.093
-
Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. Am J Cardiol. 2016 Dec 15; 118(12):1805-1811.
Score: 0.093
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.